Postoperative Effects of Different Enterostomy Approaches

Recruiting N/A Interventional Study
Colorectal Cancer Colorectal Neoplasms Malignant Intestinal Neoplasms, Malignant
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
300 (estimated)
Sponsor
Fudan University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Exploring the effect of protective ileostomy compared with transverse colostomy on the occurrence of complications, the occurrence of serious side effects of adjuvant chemotherapy and disease recurrence in patients with low rectal cancer after radical surgery from the perspective of intestinal microecology.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Pathological confirmed adenocarcinoma of the rectum; 2. Patients age between 18-80; 3. Baseline AJCC stage I-III: cT1-4N0-2M0 (AJCC-8 version); 4. Eastern Cooperative Oncology Group (ECOG) physical status score of 0 to 2; 5. Patients voluntarily sign informed consent. Exclus…
Contacts

Yanlei Ma, PhD

(86)13122680635

yanleima@fudan.edu.cn

CONTACT

Yichi Zhang, MD

(86)18588731911

22111230058@m.fudan.edu.cn

CONTACT